Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study

The United States (US) Expanded Access Program (EAP) to coronavirus disease 2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. While randomized clinical trials were in var...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Jonathon W. Senefeld, Patrick W. Johnson, Katie L. Kunze, Evan M. Bloch, Noud van Helmond, Michael A. Golafshar, Stephen A. Klassen, Allan M. Klompas, Matthew A. Sexton, Juan C. Diaz Soto, Brenda J. Grossman, Aaron A.R. Tobian, Ruchika Goel, Chad C. Wiggins, Katelyn A. Bruno, Camille M. van Buskirk, James R. Stubbs, Jeffrey L. Winters, Arturo Casadevall, Nigel Paneth, Beth H. Shaz, M. Petersen, Bruce S. Sachais, Matthew Buras, Mikolaj A. Wieczorek, Benjamin Russoniello, Larry J. Dumont, Sarah E. Baker, Ralph Vassallo, John R.A. Shepherd, Pampee P. Young, Nicole Verdun, Peter Marks, Nancy Haley, Robert F. Rea, Louis M. Katz, Vitaly Herasevich, Dan A. Waxman, Emily R. Whelan, Aviv Bergman, Andrew J. Clayburn, M. Kate Grabowski, Kathryn F. Larson, Juan G. Ripoll, Kylie J. Andersen, Matthew N.P. Vogt, Joshua J. Dennis, Riley J. Regimbal, Philippe R. Bauer, Janis E. Blair, Zachary A. Buchholtz, Michaela C. Pletsch, Katherine Wright, Joel T. Greenshields, Michael J. Joyner, R. Scott Wright, Rickey E. Carter, DeLisa Fairweather
Format: Artigo
Jezik:angleščina
Izdano: 2021
Online dostop:https://doi.org/10.1371/journal.pmed.1003872
https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003872&type=printable
Oznake: Označite
Brez oznak, prvi označite!